On 4/3/24, Lifecore Biomedical Inc (NASDAQ: LFCR) stock enjoyed a major increase of 11.4%, closing at $6.15. Moreover, this advance was accompanied by exceptionally high trading volume at 220% of normal. The stock has risen 13.9% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
LFCR's future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.
Lifecore Biomedical is currently unrated.
Rating Review
The stock is currently unrated.